Literature DB >> 181003

Impairment of hepatic microsomal and plasma esterases of the rat by disulfiram and diethyldithiocarbamate.

M A Zemaitis, F E Greene.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181003     DOI: 10.1016/0006-2952(76)90349-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

Review 1.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

2.  Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.

Authors:  Reginald F Frye; Robert A Branch
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

3.  Influence of the carboxylesterase inhibitor bis-p-nitrophenylphosphate on the rates of hydrolysis of various alpha-esters of 1-(N-methyl-N-nitrosamino)-methanol in vitro and in vivo and on the acute toxicity and carcinogenicity of 1-(N-methyl-N-nitrosamino)-methylacetate.

Authors:  N Frank; R Caesar; H R Scherf; M Wiessler
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

4.  Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures.

Authors:  Meriem Gaval-Cruz; Jason P Schroeder; L Cameron Liles; Martin A Javors; David Weinshenker
Journal:  Pharmacol Biochem Behav       Date:  2008-02-12       Impact factor: 3.533

5.  The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial.

Authors:  Colin N Haile; Richard De La Garza; James J Mahoney; David A Nielsen; Thomas R Kosten; Thomas F Newton
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.